TimiHealth is the first decentralized Healthcare Data Marketplace on the blockchain. The platform is first of its kind whose blockchain technology allows for the transfer of medical record at lightning speed, with maximum security and availability. Timicoin is the currency which fuels the Blockchain Healthcare Platform. With the Timicoin ecosystem, patients are able to access their healthcare data and DNA ancestry anywhere securely. A Patient will also be able to share their data anonymously with healthcare organization and get paid, in return. TimiHealth allows the user to own, control and monetize their personal healthcare information.
TimiHealth explained that the platform is a Blockchain as a Service (BaaS) solution, built to address the most critical issues in healthcare like – interoperability across healthcare platforms and systems, and patient-centric ‘Care Plans’ for comprehensive clinical care coordination. It also features genomic focused use cases via TimiDNA.
On January 22nd, 2019, TimiHealth announced that TimiCoin will now be listed on the premier SWFT Blockchain exchange.
“We started this project two years ago, and while everyone has been focused on HODL this past year, we were always focused on BUIDL. Moving into 2019 we strongly believe you should have a live blockchain if you want to call yourself a blockchain company, too many simply do not understand this,” said Will Lowe, the founder of TimiHealth.
TimiHealth has also released the first blockchain powered healthcare app called TimiPatient. The app is available to consumers to download in the Apple App Store and on Google Play Store.
“Our vision is direct, create tremendous value in healthcare by taking the lead on the biggest challenges that drive waste and inefficiencies, and tokenize health data to enrich the patients. Our position directly aligns with policies led by the Centers of Medicare and Medicaid Services (CMS) including their patient-centric MyHealthEData Initiative focused on putting patients in control of their data. We in parallel understand the rapid development of value from genomic data as demonstrated by the 23andMe GlaxoSmithKline 300 million dollar deal and are excited about the TimiDNA platform launching soon. We are excited to unveil both new solutions and partnerships in the coming months,” Lowe added.
SWFT Blockchain is a next-generation global cross-chain crypto transfer protocol. SWFT exchange is focused on global applications and is backed by the Draper Dragon Digital Fund from Silicon Valley. Their focus is on integrating the world’s major exchanges and blockchains to effectively hedge risks and provide customers with an efficient and easy-to-use platform for cryptocurrency transfers.